Evotec has been contracted to manage candidate APIs by Pierre Fabre

By Gareth Macdonald

- Last updated on GMT

Evotec gets compound management contract
Evotec gets compound management contract

Related tags Compound management Active ingredient Pharmacology

Evotec has been hired to manage candidate drug compounds by French privately-owned pharmaceutical firm Pierre Fabre.

The five year deal – financial terms of which were not disclosed – will see the German contract research organisation (CRO) manage Pierre Fabre’s library of potential active pharmaceutical ingredients (APIs) and collection plates.

The work will be based at Evotc’s purpose built facility in Toulouse, France according to CEO Mario Polywka.

We welcome Pierre Fabre as another partner who has entrusted their complete compound management needs.

This collaboration further validates our strategy to establish a state-of-the-art compound management operation out of Toulouse for the European market and cements our position as the world leader in outsourced compound management​.”

Compound interest

Evotec has been focused on expanding its compound management client base since October when it signed a deal with the US National Cancer Institute (NCI).

Under the €4.5 m ($4.9 m) contract with the NCI, Evotec was tasked with managing the organisation's library of early-phase candidate drug compounds.

At the time Evotec spokeswoman Gabriele Hansen told us the firm is hopeful the NCI contract would attract the attention of pharmaceutical firms interested in accessing the compounds.

History tells us that contracts with the National Institutes of Health, the NCI being one of the largest centres, attracts other collaborators, academics, non-profits, and commercial organizations, who want to access these high calibre collections​” she said.

She added that the firm aimed to attract “other prospective collaborators who are looking to build their own discovery collection while avoiding upfront costs and leveraging a proven partners capacities and capabilities.”

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more